T. Rowe Price Associates
CGON icon

T. Rowe Price Associates’s CG Oncology CGON Stock Holding History

T. Rowe Price Associates’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$247M Buy
3,652,980
+209,836
+6% +$11.9M 0.03% 408
2025
Q4 		$143M Buy
3,443,144
+1,854,386
+117% +$76.7M 0.02% 554
2025
Q3 		$64M Sell
1,588,758
-424,932
-21% -$12.4M 0.01% 722
2025
Q2 		$52.4M Buy
2,013,690
+999,094
+98% +$24.1M 0.01% 724
2025
Q1 		$24.8M Buy
1,014,596
+69,402
+7% +$1.95M ﹤0.01% 897
2024
Q4 		$27.1M Buy
945,194
+353,787
+60% +$12.1M ﹤0.01% 919
2024
Q3 		$22.3M Sell
591,407
-73,738
-11% -$2.59M ﹤0.01% 973
2024
Q2 		$21M Sell
665,145
-326,973
-33% -$11.3M ﹤0.01% 955
2024
Q1 		$43.6M Buy
+992,118
New +$40.5M 0.01% 766

Other funds holding CGON

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return